PUBLISHER: TechNavio | PRODUCT CODE: 1916100
PUBLISHER: TechNavio | PRODUCT CODE: 1916100
Global Comprehensive Metabolic Panel Testing Market 2025-2029
The global comprehensive metabolic panel testing market is forecasted to grow by USD 5839.0 mn during 2024-2029, accelerating at a CAGR of 8.6% during the forecast period. The report on the global comprehensive metabolic panel testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating incidence of chronic diseases, expanding geriatric population, technological advancements in diagnostic and laboratory automation.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 7.9% |
| CAGR | 8.6% |
| Incremental Value | $5839.0 mn |
Technavio's global comprehensive metabolic panel testing market is segmented as below:
By Application
- Kidney diseases
- Diabetes
- Liver diseases
- Others
By Test
- Kidney function tests
- Glucose
- Liver function tests
- Electrolytes
- Others
By End-User
- Laboratories
- Hospital
- Point-of-care testing
- Emergency departments
- Others
Geography
- North America
- US
- Canada
- Mexico
- Asia
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the ascendancy of point-of-care metabolic panel testing as one of the prime reasons driving the global comprehensive metabolic panel testing market growth during the next few years. Also, integration of artificial intelligence in metabolic panel analysis and expansion of at-home and direct-to-consumer metabolic panel testing will lead to sizable demand in the market.
The report on the global comprehensive metabolic panel testing market covers the following areas:
- Global comprehensive metabolic panel testing market sizing
- Global comprehensive metabolic panel testing market forecast
- Global comprehensive metabolic panel testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global comprehensive metabolic panel testing market vendors that include Abbott Laboratories, ARUP Laboratories, Beckman Coulter Inc., Bio Rad Laboratories Inc., CENTOGENE NV, DiaSorin Spa, F. Hoffmann La Roche Ltd., Laboratory Corp., Mayo Medical Laboratories, Metropolis Healthcare Ltd., Quest Diagnostics Inc., QuidelOrtho Corp., Randox Laboratories Ltd., Siemens Healthineers AG, Sonic Healthcare Ltd., SYNLAB International GmbH, Thermo Fisher Scientific Inc., Unipath Specialty Laboratory Ltd.. Also, the global comprehensive metabolic panel testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Test
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Comprehensive Metabolic Panel Testing Market 2019 - 2023
- Historic Market Size - Data Table on Global Comprehensive Metabolic Panel Testing Market 2019 - 2023 ($ million)
- 5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.3 Test segment analysis 2019 - 2023
- Historic Market Size - Test Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI in global comprehensive metabolic panel testing market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Kidney diseases - Market size and forecast 2024-2029
- 8.4 Diabetes - Market size and forecast 2024-2029
- 8.5 Liver diseases - Market size and forecast 2024-2029
- 8.6 Others - Market size and forecast 2024-2029
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Test
- 9.1 Market segments
- 9.2 Comparison by Test
- 9.3 Kidney function tests - Market size and forecast 2024-2029
- 9.4 Glucose - Market size and forecast 2024-2029
- 9.5 Liver function tests - Market size and forecast 2024-2029
- 9.6 Electrolytes - Market size and forecast 2024-2029
- 9.7 Others - Market size and forecast 2024-2029
- 9.8 Market opportunity by Test
- Market opportunity by Test ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Laboratories - Market size and forecast 2024-2029
- 10.4 Hospital - Market size and forecast 2024-2029
- 10.5 Point-of-care testing - Market size and forecast 2024-2029
- 10.6 Emergency departments - Market size and forecast 2024-2029
- 10.7 Others - Market size and forecast 2024-2029
- 10.8 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Asia - Market size and forecast 2024-2029
- 12.4.1 China - Market size and forecast 2024-2029
- 12.4.2 India - Market size and forecast 2024-2029
- 12.4.3 Japan - Market size and forecast 2024-2029
- 12.4.4 South Korea - Market size and forecast 2024-2029
- 12.4.5 Indonesia - Market size and forecast 2024-2029
- 12.4.6 Thailand - Market size and forecast 2024-2029
- 12.4.7 Singapore - Market size and forecast 2024-2029
- 12.5 Europe - Market size and forecast 2024-2029
- 12.5.1 Germany - Market size and forecast 2024-2029
- 12.5.2 UK - Market size and forecast 2024-2029
- 12.5.3 France - Market size and forecast 2024-2029
- 12.5.4 Italy - Market size and forecast 2024-2029
- 12.5.5 The Netherlands - Market size and forecast 2024-2029
- 12.5.6 Spain - Market size and forecast 2024-2029
- 12.5.7 Russia - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Australia - Market size and forecast 2024-2029
- 12.6.2 Brazil - Market size and forecast 2024-2029
- 12.6.3 UAE - Market size and forecast 2024-2029
- 12.6.4 South Africa - Market size and forecast 2024-2029
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.6 Turkey - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Escalating incidence of chronic diseases
- Expanding geriatric population
- Technological advancements in diagnostic and laboratory automation
- 13.2 Market challenges
- Stringent regulatory frameworks and compliance burdens
- Complex reimbursement policies and increasing pricing pressures
- Navigating shift towards point-of-care testing and associated data privacy concerns
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Ascendancy of point-of-care metabolic panel testing
- Integration of artificial intelligence in metabolic panel analysis
- Expansion of at-home and direct-to-consumer metabolic panel testing
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 ARUP Laboratories
- ARUP Laboratories - Overview
- ARUP Laboratories - Product / Service
- ARUP Laboratories - Key offerings
- SWOT
- 15.6 Beckman Coulter Inc.
- Beckman Coulter Inc. - Overview
- Beckman Coulter Inc. - Product / Service
- Beckman Coulter Inc. - Key offerings
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 CENTOGENE NV
- CENTOGENE NV - Overview
- CENTOGENE NV - Product / Service
- CENTOGENE NV - Key offerings
- SWOT
- 15.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.10 Laboratory Corp.
- Laboratory Corp. - Overview
- Laboratory Corp. - Business segments
- Laboratory Corp. - Key news
- Laboratory Corp. - Key offerings
- Laboratory Corp. - Segment focus
- SWOT
- 15.11 Mayo Medical Laboratories
- Mayo Medical Laboratories - Overview
- Mayo Medical Laboratories - Product / Service
- Mayo Medical Laboratories - Key offerings
- SWOT
- 15.12 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.13 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 15.14 Randox Laboratories Ltd.
- Randox Laboratories Ltd. - Overview
- Randox Laboratories Ltd. - Product / Service
- Randox Laboratories Ltd. - Key news
- Randox Laboratories Ltd. - Key offerings
- SWOT
- 15.15 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.16 Sonic Healthcare Ltd.
- Sonic Healthcare Ltd. - Overview
- Sonic Healthcare Ltd. - Business segments
- Sonic Healthcare Ltd. - Key offerings
- Sonic Healthcare Ltd. - Segment focus
- SWOT
- 15.17 SYNLAB International GmbH
- SYNLAB International GmbH - Overview
- SYNLAB International GmbH - Product / Service
- SYNLAB International GmbH - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
